Is ARMP (ARMP) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 32.8% / 30% | 2.4% / 30% | 0.2% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 32.8% / 33% | 2.4% / 33% | 0.2% / 33% | N/A | ✓ HALAL |
| MSCI | 146.4% / 33% | 10.7% / 33% | 0.9% / 33% | N/A | ✗ NOT HALAL |
| S&P | 32.8% / 33% | 2.4% / 33% | 0.2% / 33% | N/A | ✓ HALAL |
| FTSE | 146.4% / 33% | 10.7% / 33% | 0.9% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 100.0% | |
| Operating Margin | -775.2% | |
| Net Margin | 0.0% | |
| Return on Assets (ROA) | -23.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$38M |
| Free Cash Flow | -$39M |
| Total Debt | $127M |
| Current Ratio | 1.2 |
| Total Assets | $86M |
Price & Trading
| Last Close | $9.35 |
| 50-Day MA | $8.71 |
| 200-Day MA | $5.18 |
| Avg Volume | 47K |
|
52-Week Range
$0.90
| |
About ARMP (ARMP)
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is ARMP (ARMP) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), ARMP is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is ARMP's debt ratio?
ARMP's debt ratio is 32.8% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 146.4%.
What are ARMP's key financial metrics?
ARMP has a market capitalization of $307M.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.